National Council on Disability Recommends More Regulation of NIPT

Jan

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb

Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Menu

National Council on Disability Recommends More Regulation of NIPT

To read the full story....

Breaking News

In Brief This Week: Bio-Techne, PerkinElmer, Exosomics, and More

Swedish Diagnostics Firm Elypta Raises €6.1M

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

FIND-Led Consortium Awarded €6M for TB Project

Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Development of a Novel Multiplex Assay: A Partnership Case Study

What's Popular?

Quest Diagnostics Acquires Blueprint Genetics

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

Sponsorships